- bioanalysis
- biomarkers
- flow cytometry
- immunoaffinity capture
- quantitative PCR
On 23 July 2020, Bioanalysis Zone held a panel discussion on ‘Novel Techniques and The New Age of Biomarkers’. This set the stage for industry experts to focus on the vanguard of efforts in the field of bioanalysis among the challenges that the community faces today as well as explore the steps taken to address them. The discussion was categorized under three main topics: ‘New methods and techniques’; ‘The new age of biomarkers’ and ‘The current trends in nonstandard bioanalytical techniques’.
The panel was moderated by S Pasas-Farmer, PhD, President of Ariadne Software (KS, USA). The speakers included C James, PhD, Director of Bioanalytical Sciences, Amgen Research (CA, USA); C Fandozzi, PhD, Associate Vice President, Merck Research Laboratories (PA, USA); D Warrino, PhD, Senior Scientific Advisor, KCAS Bioanalytical and Biomarker Services (KS, USA); R Durham, PhD, Director of Service and Scientific Support, Gyros Protein Technologies (NJ, USA); R Hayes, PhD, VP of Bioanalytical Services, ICON plc (NY, USA); S Cape, PhD, Director of Bioanalytical Science, Covance (WI, USA) and T Olah, PhD, Group Director of Bioanalytical Research, Bristol-Myers Squibb (NJ, USA).In this commentary, highlights pertaining to the three topics from the panel discussion will be covered.